Loss of membranous NECTIN-4 occurs frequently during metastatic spread of urothelial carcinoma and predicts resistance to enfortumab vedotin

Klümper N., Ralser D.J.,Ellinger J., Roghmann F., Breyer J., Bolenz C., Zengerling F., Erben P., Schwamborn K., Horn T.,Kristiansen G., Grünwald V., Darr C., Rausch S., Schlack K., Zschäbitz S., Wullich B.,Ritter M.,Hartmann A., Gschwend J.E.

European Urology（2023）

引用 0|浏览3